180 related articles for article (PubMed ID: 24423157)
21. The utility of the proposed IASLC/ATS/ERS lung adenocarcinoma subtypes for disease prognosis and correlation of driver gene alterations.
Tsuta K; Kawago M; Inoue E; Yoshida A; Takahashi F; Sakurai H; Watanabe SI; Takeuchi M; Furuta K; Asamura H; Tsuda H
Lung Cancer; 2013 Sep; 81(3):371-376. PubMed ID: 23891509
[TBL] [Abstract][Full Text] [Related]
22. Prognostic implication of predominant histologic subtypes of lymph node metastases in surgically resected lung adenocarcinoma.
Suda K; Sato K; Shimizu S; Tomizawa K; Takemoto T; Iwasaki T; Sakaguchi M; Mitsudomi T
Biomed Res Int; 2014; 2014():645681. PubMed ID: 25371901
[TBL] [Abstract][Full Text] [Related]
23. Decreased expression of SOX7 is correlated with poor prognosis in lung adenocarcinoma patients.
Li B; Ge Z; Song S; Zhang S; Yan H; Huang B; Zhang Y
Pathol Oncol Res; 2012 Oct; 18(4):1039-45. PubMed ID: 22777918
[TBL] [Abstract][Full Text] [Related]
24. Tumor invasiveness as defined by the newly proposed IASLC/ATS/ERS classification has prognostic significance for pathologic stage IA lung adenocarcinoma and can be predicted by radiologic parameters.
Takahashi M; Shigematsu Y; Ohta M; Tokumasu H; Matsukura T; Hirai T
J Thorac Cardiovasc Surg; 2014 Jan; 147(1):54-9. PubMed ID: 24131786
[TBL] [Abstract][Full Text] [Related]
25. Nonpredominant lepidic pattern correlates with better outcome in invasive lung adenocarcinoma.
Mäkinen JM; Laitakari K; Johnson S; Mäkitaro R; Bloigu R; Lappi-Blanco E; Kaarteenaho R
Lung Cancer; 2015 Dec; 90(3):568-74. PubMed ID: 26506915
[TBL] [Abstract][Full Text] [Related]
26. Risk of development of brain metastases according to the IASLC/ATS/ERS lung adenocarcinoma classification in locally advanced and metastatic disease.
Arrieta O; Salas AA; Cardona AF; Díaz-García D; Lara-Mejía L; Escamilla I; García AP; Pérez EC; Raez LE; Rolfo C; Rosell R
Lung Cancer; 2021 May; 155():183-190. PubMed ID: 33558063
[TBL] [Abstract][Full Text] [Related]
27. Expression and prognostic value of GalNAc-T3 in patients with completely resected small (≤2 cm) peripheral lung adenocarcinoma after IASLC/ATS/ERS classification.
Zhao S; Guo T; Li J; Uramoto H; Guan H; Deng W; Gu C
Onco Targets Ther; 2015; 8():3143-52. PubMed ID: 26604783
[TBL] [Abstract][Full Text] [Related]
28. Mitosis trumps T stage and proposed international association for the study of lung cancer/american thoracic society/european respiratory society classification for prognostic value in resected stage 1 lung adenocarcinoma.
Duhig EE; Dettrick A; Godbolt DB; Pauli J; van Zwieten A; Hansen AR; Yang IA; Fong KM; Clarke BE; Bowman RV
J Thorac Oncol; 2015 Apr; 10(4):673-81. PubMed ID: 25514800
[TBL] [Abstract][Full Text] [Related]
29. [Impact of Smoking on the Histological Subtype and Outcome of the Primary Lung Adenocarcinoma].
Xu Y; Tan WW; Fan P; Yang ZZ; Zhang S; Xi JL; Wang YX; Hu X
Sichuan Da Xue Xue Bao Yi Xue Ban; 2019 Dec; 50(6):867-871. PubMed ID: 31880119
[TBL] [Abstract][Full Text] [Related]
30. Close association of IASLC/ATS/ERS lung adenocarcinoma subtypes with glucose-uptake in positron emission tomography.
Nakamura H; Saji H; Shinmyo T; Tagaya R; Kurimoto N; Koizumi H; Takagi M
Lung Cancer; 2015 Jan; 87(1):28-33. PubMed ID: 25481488
[TBL] [Abstract][Full Text] [Related]
31. Primary adenocarcinoma of the lung--histological subtypes and outcome after surgery, using the IASLC/ATS/ERS classification of lung adenocarcinoma.
Oskarsdottir GN; Bjornsson J; Jonsson S; Isaksson HJ; Gudbjartsson T
APMIS; 2016 May; 124(5):384-92. PubMed ID: 26957057
[TBL] [Abstract][Full Text] [Related]
32. Cytopathology of pulmonary adenocarcinoma with a single histological pattern using the proposed International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society (IASLC/ATS/ERS) classification.
Rodriguez EF; Dacic S; Pantanowitz L; Khalbuss WE; Monaco SE
Cancer Cytopathol; 2015 May; 123(5):306-17. PubMed ID: 25788465
[TBL] [Abstract][Full Text] [Related]
33. [Analysis of the effect of different pathological subtypes to prognosis in stage I pulmonary adenocarcinoma].
Jiang W; Xi J; Xu S; Lu S; Wang Q
Zhonghua Wai Ke Za Zhi; 2015 Oct; 53(10):737-41. PubMed ID: 26654304
[TBL] [Abstract][Full Text] [Related]
34. High incidence of EGFR mutations in Korean men smokers with no intratumoral heterogeneity of lung adenocarcinomas: correlation with histologic subtypes, EGFR/TTF-1 expressions, and clinical features.
Sun PL; Seol H; Lee HJ; Yoo SB; Kim H; Xu X; Jheon S; Lee CT; Lee JS; Chung JH
J Thorac Oncol; 2012 Feb; 7(2):323-30. PubMed ID: 22237264
[TBL] [Abstract][Full Text] [Related]
35. Does lung adenocarcinoma subtype predict patient survival?: A clinicopathologic study based on the new International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society international multidisciplinary lung adenocarcinoma classification.
Russell PA; Wainer Z; Wright GM; Daniels M; Conron M; Williams RA
J Thorac Oncol; 2011 Sep; 6(9):1496-504. PubMed ID: 21642859
[TBL] [Abstract][Full Text] [Related]
36. The new histologic classification of lung primary adenocarcinoma subtypes is a reliable prognostic marker and identifies tumors with different mutation status: the experience of a French cohort.
Mansuet-Lupo A; Bobbio A; Blons H; Becht E; Ouakrim H; Didelot A; Charpentier MC; Bain S; Marmey B; Bonjour P; Biton J; Cremer I; Dieu-Nosjean MC; Sautès-Fridman C; Régnard JF; Laurent-Puig P; Alifano M; Damotte D
Chest; 2014 Sep; 146(3):633-643. PubMed ID: 24676429
[TBL] [Abstract][Full Text] [Related]
37. Tumor cell proliferation (Ki-67) expression and its prognostic significance in histological subtypes of lung adenocarcinoma.
Li Z; Li F; Pan C; He Z; Pan X; Zhu Q; Wu W; Chen L
Lung Cancer; 2021 Apr; 154():69-75. PubMed ID: 33626488
[TBL] [Abstract][Full Text] [Related]
38. Correlation of EGFR mutation status with predominant histologic subtype of adenocarcinoma according to the new lung adenocarcinoma classification of the International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society.
Villa C; Cagle PT; Johnson M; Patel JD; Yeldandi AV; Raj R; DeCamp MM; Raparia K
Arch Pathol Lab Med; 2014 Oct; 138(10):1353-7. PubMed ID: 24571650
[TBL] [Abstract][Full Text] [Related]
39. The new IASLC-ATS-ERS lung adenocarcinoma classification: what the surgeon should know.
Eguchi T; Kadota K; Park BJ; Travis WD; Jones DR; Adusumilli PS
Semin Thorac Cardiovasc Surg; 2014; 26(3):210-22. PubMed ID: 25527015
[TBL] [Abstract][Full Text] [Related]
40. KRAS Mutation Is a Significant Prognostic Factor in Early-stage Lung Adenocarcinoma.
Kadota K; Sima CS; Arcila ME; Hedvat C; Kris MG; Jones DR; Adusumilli PS; Travis WD
Am J Surg Pathol; 2016 Dec; 40(12):1579-1590. PubMed ID: 27740967
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]